AU2001271021A1 - Process for producing glycoprotein - Google Patents

Process for producing glycoprotein

Info

Publication number
AU2001271021A1
AU2001271021A1 AU2001271021A AU7102101A AU2001271021A1 AU 2001271021 A1 AU2001271021 A1 AU 2001271021A1 AU 2001271021 A AU2001271021 A AU 2001271021A AU 7102101 A AU7102101 A AU 7102101A AU 2001271021 A1 AU2001271021 A1 AU 2001271021A1
Authority
AU
Australia
Prior art keywords
producing glycoprotein
glycoprotein
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001271021A
Inventor
Yoshio Katakura
Michimasa Kishimoto
Kaoru Kobayashi
Hideo Miki
Toyoo Ohda
Takeshi Omasa
Kenichi Suga
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Pharma Corp
Osaka University NUC
Original Assignee
Agency of Industrial Science and Technology
Mitsubishi Pharma Corp
Osaka University NUC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agency of Industrial Science and Technology, Mitsubishi Pharma Corp, Osaka University NUC filed Critical Agency of Industrial Science and Technology
Publication of AU2001271021A1 publication Critical patent/AU2001271021A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/005Glycopeptides, glycoproteins
AU2001271021A 2000-07-05 2001-07-04 Process for producing glycoprotein Abandoned AU2001271021A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000204327 2000-07-05
JP2000-204327 2000-07-05
PCT/JP2001/005812 WO2002002793A1 (en) 2000-07-05 2001-07-04 Process for producing glycoprotein

Publications (1)

Publication Number Publication Date
AU2001271021A1 true AU2001271021A1 (en) 2002-01-14

Family

ID=18701603

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001271021A Abandoned AU2001271021A1 (en) 2000-07-05 2001-07-04 Process for producing glycoprotein

Country Status (4)

Country Link
US (2) US20030170813A1 (en)
EP (1) EP1298217A4 (en)
AU (1) AU2001271021A1 (en)
WO (1) WO2002002793A1 (en)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2264166B1 (en) 1999-04-09 2016-03-23 Kyowa Hakko Kirin Co., Ltd. Method for controlling the activity of immunologically functional molecule
US6946292B2 (en) * 2000-10-06 2005-09-20 Kyowa Hakko Kogyo Co., Ltd. Cells producing antibody compositions with increased antibody dependent cytotoxic activity
DK1356068T3 (en) 2001-01-19 2015-02-16 Phyton Holdings Llc PROCESS FOR THE PRODUCTION OF secretory glycoprotein with HUMAN TYPE SUGAR CHAIN ​​FOR USING A PLANT CELL
US7691568B2 (en) 2002-04-09 2010-04-06 Kyowa Hakko Kirin Co., Ltd Antibody composition-containing medicament
ES2285188T3 (en) * 2002-07-15 2007-11-16 Immunex Corporation METHOD AND MEANS FOR CONTROLLING PROTEIN SELLING PRODUCED BY MAMMAL CELLS.
US7691810B2 (en) * 2003-10-09 2010-04-06 Kyowa Hakko Kirin Co., Ltd Method of producing recombinant antithrombin III composition
ATE554097T1 (en) * 2003-10-09 2012-05-15 Kyowa Hakko Kirin Co Ltd METHOD FOR PRODUCING ANTITHROMBIN III COMPOSITIONS
US7972810B2 (en) 2005-12-08 2011-07-05 Amgen Inc. Production of glycoproteins using manganese
WO2008069244A1 (en) * 2006-12-05 2008-06-12 Kyowa Hakko Kogyo Co., Ltd. Process for producing glycoprotein composition
CN101681396A (en) * 2007-04-16 2010-03-24 动量制药公司 Glucoprotein product that limits and associated method
JP5485869B2 (en) 2007-04-17 2014-05-07 スティヒティング ディーンスト ランドバウクンディフ オンデルズーク Mammalian glycosylation in plants by expression of non-mammalian glycosyltransferases
BRPI1008904A2 (en) 2009-02-25 2015-08-25 Univ Indiana Res & Tech Corp Variant yeast, and methods for isolating a yeast, and for creating a mutant yeast strain.
KR101860175B1 (en) * 2009-10-26 2018-05-21 에프. 호프만-라 로슈 아게 Method for the production of a glycosylated immunoglobulin
HUE039240T2 (en) 2009-11-03 2018-12-28 Grifols Therapeutics Llc Composition, method, and kit for alpha-1 proteinase inhibitor
US8648177B2 (en) 2009-11-24 2014-02-11 Grifols Therapeutics Inc. Lyophilization methods, compositions, and kits
WO2012149197A2 (en) 2011-04-27 2012-11-01 Abbott Laboratories Methods for controlling the galactosylation profile of recombinantly-expressed proteins
WO2013121509A1 (en) * 2012-02-13 2013-08-22 公立大学法人高知工科大学 Single-cell isolation method and single-cell culture method for botryococcus braunii
WO2013158279A1 (en) 2012-04-20 2013-10-24 Abbvie Inc. Protein purification methods to reduce acidic species
US9067990B2 (en) 2013-03-14 2015-06-30 Abbvie, Inc. Protein purification using displacement chromatography
US9181572B2 (en) 2012-04-20 2015-11-10 Abbvie, Inc. Methods to modulate lysine variant distribution
US9512214B2 (en) 2012-09-02 2016-12-06 Abbvie, Inc. Methods to control protein heterogeneity
CA2905010A1 (en) 2013-03-12 2014-09-18 Abbvie Inc. Human antibodies that bind human tnf-alpha and methods of preparing the same
WO2014151878A2 (en) 2013-03-14 2014-09-25 Abbvie Inc. Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosacharides
US9017687B1 (en) 2013-10-18 2015-04-28 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same using displacement chromatography
JP6563910B2 (en) 2013-07-04 2019-08-21 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft Interference suppression immunoassay for detecting anti-drug antibodies in serum samples
WO2015051293A2 (en) 2013-10-04 2015-04-09 Abbvie, Inc. Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
US9085618B2 (en) 2013-10-18 2015-07-21 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same
US9181337B2 (en) 2013-10-18 2015-11-10 Abbvie, Inc. Modulated lysine variant species compositions and methods for producing and using the same
WO2015073884A2 (en) 2013-11-15 2015-05-21 Abbvie, Inc. Glycoengineered binding protein compositions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5096816A (en) * 1990-06-05 1992-03-17 Cetus Corporation In vitro management of ammonia's effect on glycosylation of cell products through pH control
JPH06292592A (en) * 1993-02-09 1994-10-21 Snow Brand Milk Prod Co Ltd Production of glycoprotein
US5843705A (en) * 1995-02-21 1998-12-01 Genzyme Transgenic Corporation Transgenically produced antithrombin III
US5705364A (en) * 1995-06-06 1998-01-06 Genentech, Inc. Mammalian cell culture process
JPH0984582A (en) * 1995-09-21 1997-03-31 Kirin Brewery Co Ltd Animal cell having strengthened transglycosylase activity, glycoprotein having modified sugar chain, and production of the animal cell
JPH11127890A (en) * 1997-10-31 1999-05-18 Kazuo Shimada Production of glycoprotein
DE59813187D1 (en) * 1997-12-03 2005-12-15 Roche Diagnostics Gmbh PROCESS FOR THE PREPARATION OF POLYPEPTIDES WITH APPROPRIATE GLYCOSILATION

Also Published As

Publication number Publication date
WO2002002793A1 (en) 2002-01-10
US20030170813A1 (en) 2003-09-11
US20070141675A1 (en) 2007-06-21
EP1298217A4 (en) 2004-09-08
EP1298217A8 (en) 2003-08-06
EP1298217A1 (en) 2003-04-02

Similar Documents

Publication Publication Date Title
AU2001271021A1 (en) Process for producing glycoprotein
AU2001256732A1 (en) Process for producing crystal
AU2001241727A1 (en) Process for producing para-xylene
AU2001263004A1 (en) System for continuously producing gum
HUP0104566A3 (en) Process for producing n-carboxi-anhidrides
AU2002213972A1 (en) Method for producing polyisobutenylphenoles
AU2001239243A1 (en) Method for producing nanosuspensions
HK1049327A1 (en) Process for producing aminodiphenylamines
AU2001291313A1 (en) Process for making 3-amino-2-chloro-4-methylpyridine
AU2001248825A1 (en) Process for producing microsphere
AU2001272757A1 (en) Process for producing 5-fluorooxyindole and for producing intermediate therefor
AU2002212224A1 (en) Method for producing delta1-pyrrolines
AU2001260605A1 (en) Process for producing antioxidant
AU2001242735A1 (en) Process for producing camptothecin
AU2001280244A1 (en) Novel process for preparing 3-aminomethyl-4-z-methoxyiminopyrrolidine
AU2001296023A1 (en) Process for producing peptide
AU2001284442A1 (en) Process for producing fluoroalkanol
AU2001254841A1 (en) Process for producing ether
AU2001262147A1 (en) Method for producing 4-bromo- and 4-chloro-2-nitro-1-trifluoromethoxybenzene
AU2002217463A1 (en) Process for producing allumium extracts
AU8444201A (en) Process for producing fluoroalkanol
AU2001295925A1 (en) Process for producing diacetoxybutene
AU2001272448A1 (en) Method for producing dna-arrays
AU2000259759A1 (en) Process for producing a ns-fertilizer
AUPR144100A0 (en) Process for can manufacture